MedPath

Evaluation of the Effect of Calcitriol on the Percutaneous Coronary Interventio

Phase 3
Conditions
Percutaneous coronary intervention (PCI).
Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
I25.110
Registration Number
IRCT20151227025726N10
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Patients referring to Shahid Modarres hospital cath lab
Patients more than 18 years old
Patients who are candidated for elective PCI surgery

Exclusion Criteria

Serum creatinine level more than 2 mg/dL
Active metabolic bone disease
Vitamin D supplementation receivement
Consuming anti-inflammatory drugs (except aspirin and statin)
Severe hepatic disease (Child-paugh C)
Ejection fraction less than 30%
Contraindications or hypersensitivity to calcitriol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in CK-MB serum level. Timepoint: Before surgery and 24 hours after percutaneous coronary intervention. Method of measurement: Laboratory kit measuring serum level of CK-MB.;Change in Interleukin-6 serum level. Timepoint: Before surgery and 24 hours after percutaneous coronary intervention. Method of measurement: Laboratory kit measuring serum level of interleukin 6.;Change in total high sensitivity CRP serum level. Timepoint: Before surgery and 24 hours after percutaneous coronary intervention. Method of measurement: Laboratory kit measuring serum level of high sensitivity CRP.;Change in cardiac Troponin I serum level. Timepoint: Before surgery and 24 hours after percutaneous coronary intervention. Method of measurement: Laboratory kit measuring serum level of cardiac Troponin I.
Secondary Outcome Measures
NameTimeMethod
Myocardial infarction (MI). Timepoint: 90 to 100 days after intervention. Method of measurement: Check patient records and verbal interview at clinic.;The need for Percutaneous Coronary Intervention (PCI). Timepoint: 90 to 100 days after intervention. Method of measurement: Check patient records and verbal interview at clinic.;The need for Coronary Artery Bypass Graft (CABG). Timepoint: 90 to 100 days after intervention. Method of measurement: Check patient records and verbal interview at clinic.;All-cause death. Timepoint: 90 to 100 days after intervention. Method of measurement: Check patient records and telephone interview.
© Copyright 2025. All Rights Reserved by MedPath